Regulatory B cell imbalance correlates with Tfh expansion in systemic sclerosis

Objective. Systemic sclerosis (SSc) is an autoimmune disease with fibrosis, microangiopathy and immune dysfunction. B cell abnormalities characterised by autoantibody production and polyclonal B cell activation play an important role in the pathogenesis of SSc. We previously identified an expansion...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 2021-01, Vol.39 (4), p.S20-S24
Hauptverfasser: Ricard, L., Malard, F., Riviere, S., Laurent, C., Fain, O., Mohty, M., Gaugler, B., Mekinian, A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Objective. Systemic sclerosis (SSc) is an autoimmune disease with fibrosis, microangiopathy and immune dysfunction. B cell abnormalities characterised by autoantibody production and polyclonal B cell activation play an important role in the pathogenesis of SSc. We previously identified an expansion of functional and activated circulating T follicular helper (cTfh) cells in SSc patients. The aim of this study was to analyse the frequency of regulatory B (Breg) cell subsets and the correlation with Tfh in SSc patients. Methods. Circulating Breg cells CD24(hi)CD38(hi) and CD27(+)CD24(hi) levels and cTfh cells CD4(+)CXCR5(+)PD1(+) were determined by cytometry in 50 SSc patients and 32 healthy subjects. Results. The frequency of Breg cells CD24(hi)CD38(hi) and CD24(hi)CD27(+) was significantly reduced in patients with SSc as compared to controls (p=0.02 and p
ISSN:0392-856X
1593-098X
DOI:10.55563/clinexprheumatol/fq8tm9